Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Yening Tan"'
Autor:
Blair B. Madison, Deepak Patil, Maximilian Richter, Xianghong Li, Min Tong, Stacey Cranert, Xinxin Wang, Renata Martin, Haibin Xi, Yening Tan, Leslie Weiss, Karl Marquez, Julia Coronella, Devon J. Shedlock, Eric M. Ostertag
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 29, Iss , Pp 329- (2022)
Externí odkaz:
https://doaj.org/article/bb5af3e228f24807b03aaf49a133a1b3
Autor:
Yan Zhang, Anna Kozlowska, Jacqueline Fritz, Steven Wang, Rebecca Codde, Elvira Argus, Samad Ibitokou, Vanitra Richardson, Sumiti Jain, Maximilian Richter, Deepak Patil, Yening Tan, Min Tong, Lu Yao, Majid Ghoddusi, Eric Ostertag, Julia Coronella, Devon Shedlock, Yingying Zhao, Claudia Palomino La Torre, Stacey Cranert
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/45e6535029b74018bc17d63485684a5a
Autor:
Yan Zhang, Elvira Argus, Maximilian Richter, Yening Tan, Min Tong, Eric Ostertag, Julia Coronella, Devon Shedlock, Jing Qiu, Stacey Cranert, Hubert Tseng, Karl Marquez, Benjamin Cho, Christine Domingo, Leslie Weiss, Jessica Sparks
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/2851d8e7f07845d7a396acd2976cac76
Autor:
Yan Zhang, Anna Kozlowska, Jacqueline Fritz, Steven Wang, Rebecca Codde, Elvira Argus, Samad Ibitokou, Vanitra Richardson, Sumiti Jain, Maximilian Richter, Deepak Patil, Yening Tan, Min Tong, Lu Yao, Majid Ghoddusi, Eric Ostertag, Julia Coronella, Devon Shedlock
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/e665362eec294a31a75cb2b57eff3b08
Autor:
Jacqueline Fritz, Sumiti Jain, Claudia Palomino La Torre, Yening Tan, Devon J. Shedlock, Stacey Cranert, Vanitra Richardson, Min Tong, Elvira Argus, Yan Zhang, Anna Kozlowska, Eric M. Ostertag, Lu Yao, Deepak P. Patil, Rebecca Codde, Julia Coronella, Yingying Zhao, Majid Ghoddusi, Maximilian Richter, Steven Wang, Samad Ibitokou
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundWhile CAR-T have demonstrated potent activity against hematologic tumors, less success has been seen with solid tumors. Here we report generation of TSCM-enriched allogeneic MUC1-C-specific CAR T cells, P-MUC1C-ALLO1, with potential for a b
Autor:
Blair B, Madison, Deepak, Patil, Maximilian, Richter, Xianghong, Li, Min, Tong, Stacey, Cranert, Xinxin, Wang, Renata, Martin, Haibin, Xi, Yening, Tan, Leslie, Weiss, Karl, Marquez, Julia, Coronella, Devon J, Shedlock, Eric M, Ostertag
Publikováno v:
Molecular therapy. Nucleic acids. 29
The use of T cells from healthy donors for allogeneic chimeric antigen receptor T (CAR-T) cell cancer therapy is attractive because healthy donor T cells can produce versatile off-the-shelf CAR-T treatments. To maximize safety and durability of allog
Autor:
Jacqueline Fritz, Sumiti Jain, Yan Zhang, Vanitra Richardson, Elvira Argus, Lu Yao, Yening Tan, Deepak P. Patil, Maximilian Richter, Julia Coronella, Min Tong, Anna Kozlowska, Steven Wang, Rebecca Codde, Majid Ghoddusi, Samad Ibitokou, Eric M. Ostertag, Devon J. Shedlock
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background MUC1 is a highly glycosylated protein that is expressed at the apical border of mucosal epithelium where it plays a protective role. MUC1 is comprised of an N-terminal subunit (MUC1N) tethered to a C-terminal subunit (MUC1C), forming a sta
Autor:
Jing Qiu, Eric M. Ostertag, Yening Tan, Elvira Argus, Stacey Cranert, Benjamin Cho, Christine Domingo, Hubert Tseng, Jessica Sparks, Leslie Weiss, Julia Coronella, Min Tong, Karl Marquez, Devon J. Shedlock, Maximilian Richter, Yan Zhang
Publikováno v:
Blood. 138:4802-4802
The emergence of CAR-T cell therapy has transformed the treatment of the previously refractory/relapsed multiple myeloma (MM). Yet, autologous CAR-T cells suffer from inconsistent manufacturing, long manufacturing timelines, and high cost, which can
Autor:
Devon J. Shedlock, Min Tong, Maximilian Richter, Eric M. Ostertag, Christine Domingo, Stacey Cranert, Benjamin Cho, Leslie Weiss, Yening Tan, Julia Coronella, Karl Marquez, Yan Zhang, Jing Qiu, Elvira Argus, Hubert Tseng, Jessica Sparks
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundThe emergence of CAR-T cell therapy has transformed the treatment of refractory/relapsed multiple myeloma (MM). Yet, autologous CAR-T cells suffer from many manufacturing challenges including mainly consistency, toxicity, and cost. To addre
Autor:
Julia Coronella, Devon J. Shedlock, Eric M. Ostertag, Maximilian Richter, Leslie Weiss, Min Tong, Yening Tan, Stacey Cranert
Publikováno v:
Blood. 134:4445-4445
Chimeric Antigen Receptor (CAR) T cell therapy has generated unprecedented efficacy in the treatment of multiple hematologic malignancies. For relapsed/refractory Multiple Myeloma (MM), autologous CAR-T products directed against the B cell maturation